Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen

Clinical and Experimental Allergy

Volumn 39, Issue 3, 2009, Pages 401-408

  Stelmach, I ^a   Kaczmarek Wozniak J ^a   Majak, P ^a   Olszowiec Chlebna, M ^a   Jerzynska, J ^a  

^a N Copernicus Hospital   (Poland)

Author keywords

Asthma; Children; Immunotherapy; Rush; Sublingual

Indexed keywords

GRASS POLLEN EXTRACT; GRASS POLLEN VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; PLACEBO; STALORAL; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EYE ALLERGY; FEMALE; FORCED EXPIRATORY VOLUME; GRASS POLLEN; HEADACHE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUTH DISEASE; NOSE ALLERGY; PEAK EXPIRATORY FLOW; POLLEN ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH PAIN; SUBLINGUAL ITCHING; SYMPTOM; VITAL CAPACITY;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANTIGENS, PLANT; ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; PEAK EXPIRATORY FLOW RATE; POACEAE; POLLEN; TREATMENT OUTCOME;

EID: 58849141205     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.03159.x     Document Type: Article

References (24)

1. Serra HM, Alignani DO, Passalacqua G, Canonica GW, Correa SG. What do we need to learn to optimize the SLIT alternative. Allerg Immunol (Paris) 2006 38 : 158 65.
2. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006 117 : 1021 35.
3. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systemic review of randomized-clinical trials using the Cochrane Collaboration. Allergy 2006 61 : 1162 72.
4. Kaczmarek J, Stelmach I. Sublingual specific immunotherapy, efficacy, safety, immune mechanisms - current knowledge. Pediatr Pol 2007 82 : 635 46.
5. Tripodi S, Di Rienzo Businco A, Benincori N, Scale G, Pingitore G. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Allergy Immunol 2006 139 : 149 52.
6. Gammeri E, Arena A, D'Anneo R, La Grutta S. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol 2005 33 : 142 4.
7. Rossi RE, Moasterolo G. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual immunotherapy in 679 patients(699sessions) with allergic rhinitis and/or asthma. Immunopathol Pharmacol 2005 18 : 277 85.
8. Alvarez-Cuesta E, Bousquet J, Canonica GW et al. EAACI, Immunotherapy Task Force. Allergy 2006 61 (Suppl. 82) : 1 20.
9. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997 10 : 646 51.
10. Wasserfallen JB, Gold K, Schulman KA, Baraniuk JN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 1997 100 : 16 22.
11. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J. Standardisation of lung function tests: 1993 update. Report Working Party for the European Community for Steel and Coal. Eur Respir J 1993 6 : 5 40.
12. Quanjer PhH, Helms P, Bjure J, Gaultier CI. Standardisation of lung function tests in pediatrics. Eur Respir J 1989 2 : 121 264.
13. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005 26 : 319 38.
14. Cirla AM, Cirla PE, Parmiani S, Perora S. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of Grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Allergol Immunopathol 2003 31 : 31 43.
15. Valvorita E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006 61 : 1177 83.
16. Penagos M, Passalacqua G, Compalati E et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008 133 : 599 609.
17. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics 1984 40 : 1079 87.
18. Lehmacher W, Wassmer G, Reitmer P. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 1991 47 : 511 21.
19. Penagos M, Compalati E, Tarantini F et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006 97 : 141 8.
20. Rolinck-Werninghaus C, Wolf H, Liebke C et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 59 : 1285 93.
21. Durham SR, Yang WH, Pedersen MR, Johansen R, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006 117 : 802 9.
22. Vervloet D, Birnbaum J, Laurent P et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in Cypress rhinoconjunctivitis. Allergy Immunol 2007 142 : 239 46.
23. Andre C, Vatrinet C, Galvain C, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000 121 : 229 34.
24. Tripodi S, Di Rienzo Businco A, Benincori N, Scala G, Pingitore G. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006 139 : 149 52.